title: Port site recurrences after laparoscopic and thoracoscopic procedures in malignancy.
abstract: OBJECTIVE
  A review of the literature was performed to determine the number of cases of port site recurrences (PSR) after laparoscopy or thoracoscopy. CANCERLINE and MEDLINE were searched, as were citings from retrieved and related papers.
  
  
  RESULTS
  There have been 35 reported cases of PSR after laparoscopic colectomy for colorectal carcinoma, and 23 cases after thoracoscopic procedures for lung neoplasms. All of these have been reported since 1993. Since 1991, 12 cases have been described after laparoscopic cholecystectomy of unsuspected gallbladder carcinoma, and another case after biopsy of a known gallbladder carcinoma. Ten cases of PSR have been reported after laparoscopic procedures for ovarian lesions, often in the presence of peritoneal seeding at diagnosis. Other rare PSRs have been documented after several procedures in various malignancies.
  
  
  CONCLUSIONS
  Enrollment of patients onto the ongoing intergroup study evaluating open versus laparoscopic resection of colon cancer should be encouraged. Until valid prospective data on PSR frequency are available, laparoscopic or thoracoscopic resection of malignancy off-protocol should be undertaken with circumspection.
authors.affiliation: Clinical Investigations Department, Naval Medical Center, San Diego, CA 92134-5000, USA. pajohnst@snd10.med.navy.mil
authors.forename: P A
authors.initials: PA
authors.lastname: Johnstone
authors.forename: D C
authors.initials: DC
authors.lastname: Rohde
authors.forename: S E
authors.initials: SE
authors.lastname: Swartz
authors.forename: J E
authors.initials: JE
authors.lastname: Fetter
authors.forename: S D
authors.initials: SD
authors.lastname: Wexner
mesh_terms: D015179:Colorectal Neoplasms / Q000601:surgery; D006801:Humans; D010535:Laparoscopy / Q000009:adverse effects*; D008175:Lung Neoplasms / Q000601:surgery; D009366:Neoplasm Seeding; D011677:Punctures / Q000009:adverse effects; D013906:Thoracoscopy / Q000009:adverse effects*